Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 30, 2007
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/48/35405    most recent
M705814200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pilecka, I.
Right arrow Articles by Hooft van Huijsduijnen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pilecka, I.
Right arrow Articles by Hooft van Huijsduijnen, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print October 4, 2007
J. Biol. Chem, 10.1074/jbc.M705814200
Submitted on July 16, 2007
Revised on September 4, 2007
Accepted on October 4, 2007

Protein tyrosine phosphatase H1 (PTP-H1/PTPN3) controls growth hormone receptor signaling and systemic growth

Iwona Pilecka, Claudia Patrignani, Rosanna Pescini, Marie-Laure Curchod, Dominique Perrin, Yingzi Xue, Jason Yasenchak, Ann Clark, Maria Chiara Magnone, Paola Zaratin, David Valenzuela, Christian Rommel, and Rob Hooft van Huijsduijnen

Target Research, Merck Serono, Geneva 1202

Corresponding Author: rob.hooft{at}merckserono.net

Several Protein Tyrosine Phosphatases (PTPs) have been implicated in the control of Growth Hormone Receptor (GHR) signaling, but none have been shown to affect growth in vivo. We have applied a battery of molecular and cellular approaches to test a family-wide panel of PTPs for interference with GHR signaling. Among the subset of PTPs that showed activity in multiple readouts we selected PTP-H1/PTPN3 for further in vivo studies and found that mice lacking the PTP-H1 catalytic domain show significantly enhanced growth over their wild-type littermates. In addition, PTP-H1 mutant animals had enhanced plasma and liver mRNA expression of Insulin-like Growth Factor-1 (IGF-1), as well as increased bone density and mineral content. These observations point to a controlling role for PTP-H1 in modulating GHR signaling and systemic growth through IGF-1 secretion.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement